Related Experiment Video
Updated: Aug 7, 2026

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
Transforming activity of DNA from rat liver tumors induced by the carcinogen methyl(acetoxymethyl)nitrosamine
M Goyette1, M Dolan, W Kaufmann
1Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.
Abstract:
Altered c-Ha-ras genes have been frequently detected in the DNA of spontaneous or chemically induced mouse liver tumors. To determine if ras gene mutation is a frequent event during liver carcinogenesis in rats, we examined the transforming activity of DNA from liver tumors that developed in rats injected with methyl(acetoxymethyl)nitrosamine (DMN-OAc) after a partial hepatectomy. Three weeks after the injection of DMN-OAc, rats were fed a diet containing phenobarbital. This carcinogen acts only on replicating liver cells. Six of eight tumor DNAs induced the transformation of NIH 3T3 cells. The transforming activity was stable upon a second round of transfection, and the transformants were tumorigenic in nude mice. Southern blot analysis of transformant DNAs showed that the transforming activity was not due to the acquisition of a ras (Ha, Ki, or N), neu, myc, A-raf, v-raf, erbA, or erbB gene of rat origin. Several transformants' restriction enzyme sensitivity was analyzed, and their activity indicated that similar transforming sequences were present in at least two tumors and that one tumor contained two different transforming sequences. These results suggest that during hepatocarcinogenesis induced in rats by DMN-OAc, alterations in the ras gene family occur infrequently or not at all and that several different genes (which are not homologous to common oncogenes) become activated and are capable of transforming NIH 3T3 cells.
Insights
Ras gene mutations are infrequent in rat liver cancer induced by methyl(acetoxymethyl)nitrosamine. Instead, other activated genes, not homologous to common oncogenes, drive tumor development and NIH 3T3 cell transformation.
Area of Science:
- Oncology
- Molecular Biology
- Hepatocarcinogenesis
Background:
- Altered c-Ha-ras genes are common in mouse liver tumors.
- Ras gene mutations are suspected drivers of carcinogenesis.
Purpose of the Study:
- To investigate ras gene mutation frequency during rat liver carcinogenesis.
- To identify activated oncogenes in methyl(acetoxymethyl)nitrosamine-induced rat liver tumors.
Main Methods:
- Induction of rat liver tumors using methyl(acetoxymethyl)nitrosamine and phenobarbital.
- DNA extraction from tumors and NIH 3T3 cell transfection assays.
- Southern blot analysis to identify transforming genes in transfectants.
Main Results:
- Six of eight tumor DNAs induced NIH 3T3 cell transformation.
- Transforming activity was stable and tumorigenic in nude mice.
- Ras gene family members (Ha, Ki, N), neu, myc, A-raf, v-raf, erbA, or erbB were not responsible for transformation.
Conclusions:
- Ras gene alterations are infrequent in this rat hepatocarcinogenesis model.
- Novel, non-ras oncogenes are activated during DMN-OAc-induced liver cancer.
- These activated genes are capable of NIH 3T3 cell transformation.
Related Concept Videos
In-vitro Mutagenesis
Abnormal Proliferation
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations

